God's Life Health Care
Achieving 85-90% Success Rates with World-Class BMT Programs at 60-70% Lower Cost Than Western Countries
Dr. Anjali Mehta
Senior Hematologist & BMT Specialist
Bone Marrow Transplant (BMT), also known as hematopoietic stem cell transplant, is a life-saving procedure for patients with blood cancers, bone marrow failure syndromes, and certain genetic disorders. Apollo Hospitals, India, stands as a global leader in BMT, having performed over 4,000 transplants with success rates comparable to the world's best centers, at just 30-40% of Western costs.
Bone marrow is the spongy tissue inside bones that produces blood cells: red blood cells (carry oxygen), white blood cells (fight infection), and platelets (help blood clot). A BMT replaces damaged or diseased bone marrow with healthy stem cells that can grow new, healthy bone marrow.
Apollo Hospitals established India's first private sector BMT unit in 1995 and has since become Asia's largest BMT program. The hospital's comprehensive approach combines advanced technology, experienced specialists, and patient-centered care in dedicated BMT units with HEPA-filtered positive pressure rooms.
| Parameter | Apollo Hospitals (India) | US Hospitals | European Hospitals |
|---|---|---|---|
| Autologous BMT Cost | ₹25-35 Lakhs ($30,000-$42,000) | $150,000-$300,000 | €120,000-€250,000 |
| Allogeneic BMT Cost | ₹35-50 Lakhs ($42,000-$60,000) | $250,000-$500,000 | €200,000-€400,000 |
| Success Rate (Autologous) | 85-90% | 85-92% | 84-90% |
| Success Rate (Allogeneic) | 60-70% | 65-75% | 60-72% |
| GvHD Incidence | 30-40% | 35-45% | 32-42% |
Comprehensive medical evaluation, HLA typing, donor search (if needed), disease staging, and fertility preservation counseling. International patient coordinators assist with medical visa, travel, and accommodation.
High-dose chemotherapy and/or radiation to destroy diseased bone marrow and suppress immune system. Managed in specialized isolation rooms with HEPA filtration.
Stem cells infused intravenously (similar to blood transfusion). Process takes 1-5 hours. Stem cells migrate to bone marrow to begin engraftment.
Close monitoring for engraftment signs, infection prevention, and supportive care. Average hospital stay: 3-4 weeks for allogeneic, 2-3 weeks for autologous transplants.
Regular monitoring for complications, immune recovery, and disease remission. Monthly visits for first 6 months, then quarterly. Telemedicine available for international patients.
From Australia, AML Treatment
"Diagnosed with AML, I faced treatment costs of $350,000 in Australia. At Apollo, I received world-class care including a matched sibling BMT for just $55,000. Two years later, I'm cancer-free and back to full-time work."
From UK, Multiple Myeloma
"After relapse following chemotherapy, Apollo offered me an autologous transplant with CAR-T cell therapy. The medical team was exceptional, and the facilities were better than many UK hospitals. I saved £180,000 compared to UK costs."
Bone Marrow Transplant represents one of modern medicine's most significant advances in treating blood disorders and cancers. Apollo Hospitals, India, has established itself as a global center of excellence for BMT, offering outcomes comparable to the world's best centers at a fraction of the cost. With over 4,000 successful transplants, JACIE accreditation, and a comprehensive donor registry, Apollo provides hope to patients worldwide.
The combination of experienced medical teams, state-of-the-art technology, personalized care protocols, and significant cost advantages makes India, and specifically Apollo Hospitals, an optimal choice for patients considering bone marrow transplantation. International patients benefit not only from world-class medical care but also from comprehensive support services including travel coordination, accommodation assistance, and post-transplant follow-up care.
Contact our international patient coordinators for a free second opinion, cost estimate, donor search initiation, and assistance with medical visa and travel arrangements.
Get Free Expert Consultation
Senior Hematologist & BMT Specialist
With 20+ years of experience, Dr. Mehta has performed over 500 BMT procedures. Trained at MD Anderson Cancer Center (USA), she leads Apollo's Advanced BMT Program and specializes in haploidentical transplants.
Key considerations for transplant candidacy: